The CMS Innovation Center is seeking feedback on the Medicare $2 Drug List (M2DL) voluntary model that would test whether standardized cost sharing for low-cost generics can improve medication adherence and health outcomes along with Medicare beneficiaries' and prescribers' satisfaction with the Part D program.
The model is designed...
